18,587 articles
Marius Wernig
Marius Wernig is a stem cell biologist and Professor of Pathology at Stanford University who in 2010 converted skin fibroblasts directly into functional neurons, skipping the stem cell stage.
Mariusz Nowacki
Mariusz Nowacki (NOWACKI Mariusz) is a Swiss-based molecular geneticist, Full Professor of Genetics and Director of the Institute of Cell Biology at the University of Bern, studying small-RNA-guided genome rewriting.
Marı́a A. Blasco
María A. Blasco is a Spanish molecular biologist studying telomeres and telomerase in cancer and aging, who directed the Spanish National Cancer Research Centre in Madrid.
Marja Jäättelä
Marja Jäättelä, born in Finland in 1963, is a cancer biologist in Denmark known for work on lysosomal cell death, autophagy, and cancer metabolism, directing the CARD research center.
Marjo S. van der Knaap
Marjo S. van der Knaap is a Dutch child neurologist known for diagnosing leukodystrophies, rare genetic white matter diseases, by MRI pattern and tracing them to genes.
Mark A. Bradford
Mark A. Bradford is an American ecosystem ecologist and E.H. Harriman Professor at the Yale School of the Environment, known for a 2016 Nature study quantifying global soil carbon losses under warming.
Mark A. Creager
Mark A. Creager is an American cardiologist and vascular medicine researcher at Dartmouth's Geisel School of Medicine who served as President of the American Heart Association.
Mark A. Hlatky
Mark A. Hlatky is an American cardiologist and emeritus Stanford professor of health policy and medicine, known for the 2009 Lancet analysis of bypass surgery versus angioplasty.
Mark A. Israel
Mark A. Israel is an American physician-scientist known for research on the genetics of childhood nervous-system tumors and for directing Dartmouth's Norris Cotton Cancer Center.
Mark A. Kay
Mark A. Kay (born 1958 in Flint, Michigan) is an American physician-scientist, professor of pediatrics and genetics at Stanford, known for liver-directed gene therapy and RNA biology.
Mark A. Klebanoff
Mark A. Klebanoff, known as Mark Klebanoff, is an American pediatrician and perinatal epidemiologist at Nationwide Children's Hospital and Ohio State known for trials of bacterial vaginosis treatment to prevent preterm birth.
Mark A. Knepper
Mark A. Knepper is an American kidney physiologist and physician-scientist who heads the Epithelial Systems Biology Laboratory at the National Heart, Lung, and Blood Institute in Bethesda, Maryland.
Mark A. Lemmon
Mark A. Lemmon is an American biochemist and structural biologist who studies how cell-surface growth factor receptors such as EGFR transmit signals, and chairs Pharmacology at Yale School of Medicine.
Mark A. McNiven
Mark A. McNiven is an American cell biologist at Mayo Clinic who studies dynamin and membrane trafficking in liver and pancreas cells, organs prone to deadly cancers.
Mark A. Mintun
Mark A. Mintun is an American nuclear medicine physician-scientist who produced the first in vivo PET visualization of brain neuroreceptors and led development of donanemab.
Mark A. Rubin
Mark A. Rubin is an American pathologist and prostate cancer genomics researcher who helped define the molecular landscape of prostate cancer and leads precision medicine at the University of Bern.
Mark A. Socinski
Mark A. Socinski is an American medical oncologist specializing in lung cancer and mesothelioma, and Executive Medical Director of the AdventHealth Cancer Institute in Orlando, Florida.
Mark A. Sussman
Mark A. Sussman is an American cardiovascular molecular biologist, Distinguished Professor of Biology at San Diego State University, known for research on cardiomyocyte survival and cardiac regeneration.
Mark A. Wainberg
Mark A. Wainberg (1945–2017) was a Canadian virologist at McGill University and the first in Canada to work directly on HIV, best known for identifying the antiretroviral drug 3TC (lamivudine) in 1989.
Mark Abie Horowitz
Mark Abie Horowitz is an Australian-trained psychiatrist and researcher at University College London, co-author of the 2022 review that found no support for the serotonin theory of depression.
Mark Achtman
Mark Achtman is a microbial population geneticist, Royal Society Fellow, and co-inventor of multilocus sequence typing who traces bacterial pathogens like Helicobacter pylori against human migration.
Mark B. Faries
Mark B. Faries is an American surgical oncologist and melanoma specialist who leads Surgical Oncology at The Angeles Clinic in Los Angeles and led the MSLT-II trial.
Mark B. Feinberg
Mark B. Feinberg is an American physician-scientist who has led the International AIDS Vaccine Initiative as president and CEO since 2015, after 11 years at Merck Vaccines.
Mark B. Pepys
Mark B. Pepys is a British physician and immunologist at University College London who founded the National Amyloidosis Centre and developed imaging and antibody treatments for amyloidosis.
Mark Bathe
Mark Bathe is a biological engineer and Professor at MIT who leads the Bathe BioNanoLab, known for DNA origami design algorithms and DNA-based vaccine scaffolds.
Mark Blaxter
Mark L. Blaxter is a British evolutionary genomicist who leads the Tree of Life Programme at the Wellcome Sanger Institute and directs the Darwin Tree of Life project.
Mark Bothwell
Mark Bothwell is a neuroscientist and professor of neurobiology at the University of Washington known for work on neurotrophins, the growth factors that control neuron survival.
Mark Bower
Mark Bower is a British medical oncologist, Professor at Imperial College London and consultant at Chelsea and Westminster Hospital, known for AIDS-related cancer care and a 2006 Kaposi's sarcoma prognostic index.
Mark C. Fishman
Mark C. Fishman is an American developmental biologist, geneticist, and cardiologist, a Harvard professor known for establishing the zebrafish as a genetic model of heart development and for leading Novartis research.
Mark C. Genovese
Mark C. Genovese is an American rheumatologist who spent over two decades at Stanford leading phase 3 trials of rheumatoid arthritis drugs, then joined Gilead Sciences in 2020.